Old Web
English
Sign In
Acemap
>
authorDetail
>
Vanessa C. Williams
Vanessa C. Williams
Merck Sharp & Dohme Federal Credit Union
Endocrinology
Internal medicine
Medicine
Antagonist
Insulin
3
Papers
84
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus
1991
Metabolism-clinical and Experimental
F.Javier Ortiz-Alonso
William H. Herman
Barry J. Gertz
Vanessa C. Williams
Marla J. Smith
Jeffrey B. Halter
Show All
Source
Cite
Save
Citations (24)
Regulation of Pancreatic Endocrine Function by Cholecystokinin: Studies with MK-329, a Nonpeptide Cholecystokinin Receptor Antagonist*
1990
The Journal of Clinical Endocrinology and Metabolism
Rodger A. Liddle
Barry J. Gertz
Shuji Kanayama
Lorna Beccaria
Thomas W. Gettys
Ian L. Taylor
Robert J. Rushakoff
Vanessa C. Williams
Lisa D. Coker
Show All
Source
Cite
Save
Citations (47)
Assessment of MK‐912, an α2‐adrenoceptor antagonist, with use of intravenous clonidine
1989
Clinical Pharmacology & Therapeutics
John B. Warren
C.T. Dollery
R.W. Fuller
Vanessa C. Williams
Barry J Gertz
Show All
Source
Cite
Save
Citations (13)
1